Monthly Communication Report

Organization:	Amyotrophic Lateral Sclerosis Society of Canada/Société Canadienne de la Sclérose Latérale Amyotrophique
Associated registration:	895134-16791-35
Communication date:	2025-10-02
Posted date:	2025-10-15

Designated Public Office Holders who participated in the communication:	Dr. Jane Rylett, Scientific Director of the CIHR Institute of Aging Canadian Institutes of Health Research (CIHR) Dr. Patricia Conrod, Scientific Director of the CIHR Institute of Neurosciences, Mental Health and Addiction Canadian Institutes of Health Research (CIHR)
List of Details Subject matter Detail Health, Research and Development, Science and Technology Policies or programs related to access to care and potential treatments for the ALS Community. Budget, Health, Research and Development, Science and Technology To provide funding for neuromuscular diseases, one of which is ALS, with regards to reinstating funding from the government to help fund researchers in the neuromuscular field. Sources of funding are to be determined.
Communication Report amended on:	2025-10-15 previous entry: 16791-648818
Reason for amendment:	All meetings from Lobby Day were inadvertently consolidated into one communication
Responsible Officer who filed this communication report:	Tammy Moore
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.